Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Mallinder

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Screening|February 13, 2009
Identification of iNOS inhibitors using InteraXPhilip R Mallinder, Alan V Wallace, Gary Allenby
Protein Expression and Purification|May 14, 2009
E. coli expression and purification of human and cynomolgus IL-15Alison Ward, Malcolm Anderson, Robert I Craggs, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2011
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary diseaseAndrew Churg, Caroline V Marshall, Don D Sin, et al.
Molecular Pharmacology|August 5, 2008
Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2David J Nicholls, Nick P Tomkinson, Katherine E Wiley, et al.
Journal of Molecular Biology|December 21, 2010
Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratopeDavid C Lowe, Stefan Gerhardt, Alison Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid TumorsAni S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
Journal of Molecular Biology|July 5, 2011
Whole-molecule antibody engineering: generation of a high-affinity anti-IL-6 antibody with extended pharmacokineticsDonna K Finch, Matthew A Sleeman, Jacques Moisan, et al.
Scientific Reports|February 9, 2019
Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1Katherine A Vousden, Tomas Lundqvist, Bojana Popovic, et al.
Nature Chemical Biology|October 14, 2008
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthaseElsa D Garcin, Andrew S Arvai, Robin J Rosenfeld, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Screening|February 13, 2009
Identification of iNOS inhibitors using InteraXPhilip R Mallinder, Alan V Wallace, Gary Allenby
Protein Expression and Purification|May 14, 2009
E. coli expression and purification of human and cynomolgus IL-15Alison Ward, Malcolm Anderson, Robert I Craggs, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2011
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary diseaseAndrew Churg, Caroline V Marshall, Don D Sin, et al.
Molecular Pharmacology|August 5, 2008
Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2David J Nicholls, Nick P Tomkinson, Katherine E Wiley, et al.
Journal of Molecular Biology|December 21, 2010
Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratopeDavid C Lowe, Stefan Gerhardt, Alison Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid TumorsAni S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
Journal of Molecular Biology|July 5, 2011
Whole-molecule antibody engineering: generation of a high-affinity anti-IL-6 antibody with extended pharmacokineticsDonna K Finch, Matthew A Sleeman, Jacques Moisan, et al.
Scientific Reports|February 9, 2019
Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1Katherine A Vousden, Tomas Lundqvist, Bojana Popovic, et al.
Nature Chemical Biology|October 14, 2008
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthaseElsa D Garcin, Andrew S Arvai, Robin J Rosenfeld, et al.
Pageof 1